Benjamin Hoehn

706 total citations
9 papers, 557 citations indexed

About

Benjamin Hoehn is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Benjamin Hoehn has authored 9 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Benjamin Hoehn's work include Peripheral Neuropathies and Disorders (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Benjamin Hoehn is often cited by papers focused on Peripheral Neuropathies and Disorders (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Benjamin Hoehn collaborates with scholars based in United States, Bangladesh and Netherlands. Benjamin Hoehn's co-authors include Gary K. Steinberg, Theo D. Palmer, Midori A. Yenari, Robert M. Sapolsky, Lijun Xu, Thomas Ringer, Rona G. Giffard, RM Sapolsky, Nam Kyu Kim and Nayoung Kim and has published in prestigious journals such as Neurology, Stroke and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Benjamin Hoehn

9 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Hoehn United States 7 270 158 130 95 86 9 557
Jianfeng Liang China 11 262 1.0× 257 1.6× 63 0.5× 138 1.5× 103 1.2× 21 617
Kara Pekarek United States 5 211 0.8× 158 1.0× 155 1.2× 63 0.7× 35 0.4× 5 542
Lucie Janečková Czechia 16 397 1.5× 116 0.7× 110 0.8× 269 2.8× 51 0.6× 29 846
Hiramani Dhungana Finland 14 260 1.0× 292 1.8× 61 0.5× 72 0.8× 70 0.8× 23 703
Ulrike Harms Germany 11 263 1.0× 80 0.5× 31 0.2× 100 1.1× 67 0.8× 12 527
Michelle D. Ashley United States 8 229 0.8× 50 0.3× 111 0.9× 118 1.2× 52 0.6× 10 444
Jie Peng China 8 216 0.8× 95 0.6× 188 1.4× 78 0.8× 71 0.8× 13 495
Cheri Barrett United States 7 146 0.5× 116 0.7× 145 1.1× 148 1.6× 42 0.5× 8 490
Mary Nivison United States 9 302 1.1× 128 0.8× 112 0.9× 80 0.8× 59 0.7× 14 601
Adam C. Vana United States 9 246 0.9× 191 1.2× 409 3.1× 144 1.5× 96 1.1× 9 644

Countries citing papers authored by Benjamin Hoehn

Since Specialization
Citations

This map shows the geographic impact of Benjamin Hoehn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hoehn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hoehn more than expected).

Fields of papers citing papers by Benjamin Hoehn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Hoehn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hoehn. The network helps show where Benjamin Hoehn may publish in the future.

Co-authorship network of co-authors of Benjamin Hoehn

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Hoehn. A scholar is included among the top collaborators of Benjamin Hoehn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Hoehn. Benjamin Hoehn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mohammad, Quazi Deen, Zhahirul Islam, Nowshin Papri, et al.. (2025). Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome. Journal of the Peripheral Nervous System. 30(1). e70009–e70009. 6 indexed citations
2.
Islam, Zhahirul, Peter J. Collins, Benjamin Hoehn, et al.. (2025). Efficacy and Safety of Targeted Immunotherapy with ANX005 in Treating Guillain-Barré Syndrome: A Phase 3 Multicenter Study (PL5.006). Neurology. 104(7_Supplement_1). 4 indexed citations
5.
Oh, TaeJeong, Nayoung Kim, Benjamin Hoehn, et al.. (2013). Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer. Journal of Molecular Diagnostics. 15(4). 498–507. 129 indexed citations
6.
Hoehn, Benjamin, Theo D. Palmer, & Gary K. Steinberg. (2005). Neurogenesis in Rats After Focal Cerebral Ischemia is Enhanced by Indomethacin. Stroke. 36(12). 2718–2724. 200 indexed citations
7.
Hoehn, Benjamin, Midori A. Yenari, RM Sapolsky, & Gary K. Steinberg. (2003). Glutathione Peroxidase Overexpression Inhibits Cytochrome c Release and Proapoptotic Mediators to Protect Neurons From Experimental Stroke. Stroke. 34(10). 2489–2494. 69 indexed citations
8.
Hoehn, Benjamin, Sami I. Harik, & Antal G. Hudetz. (2002). VEGF mRNA expressed in microvessels of neonatal and adult rat cerebral cortex. Molecular Brain Research. 101(1-2). 103–108. 15 indexed citations
9.
Hoehn, Benjamin, Thomas Ringer, Lijun Xu, et al.. (2001). Overexpression of HSP72 after Induction of Experimental Stroke Protects Neurons from Ischemic Damage. Journal of Cerebral Blood Flow & Metabolism. 21(11). 1303–1309. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026